Citation
81 FR 85983
Multiple canonical documents share this first-page citation.
- National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting Tuesday, November 29, 2016 81 FR 85983
- National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting Tuesday, November 29, 2016 81 FR 85983
- Agency Information Collection Activities: Submission for OMB Review; Comment Request Tuesday, November 29, 2016 81 FR 85983
- Agency Information Collection Activities: Submission for OMB Review; Comment Request Tuesday, November 29, 2016 81 FR 85983
- Prospective Grant of Exclusive Patent License: Development and Commercialization of Dopamine D3 Receptor Selective Antagonists/Partial Agonists for the Treatment of Opioid Use Disorder, Schizophrenia Bipolar Disorder and Tetrahydrocannabinol Dependence Tuesday, November 29, 2016 81 FR 85982
- Prospective Grant of Exclusive Patent License: Development and Commercialization of Dopamine D3 Receptor Selective Antagonists/Partial Agonists for the Treatment of Opioid Use Disorder, Schizophrenia Bipolar Disorder and Tetrahydrocannabinol Dependence Tuesday, November 29, 2016 81 FR 85982
- Federal Register Vol. 81, No.229, November 29, 2016 Tuesday, November 29, 2016 81 FR 85983